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(57) ABSTRACT
A method of manufacturing and/or using a scaffold assembly
for stem cell culture and tissue engineering applications is
disclosed. The scaffold at least partially mimics a native
biological environment by providing biochemical, topo-
graphical, mechanical and electrical cues by using an elec-
troactive material. The assembly includes at least one layer
of substantially aligned, electrospun polymer fiber having an
operative connection for individual voltage application. A
method of cell tissue engineering and/or stem cell differen-
tiation that uses the assembly seeded with a sample of cells
suspended in cell culture media, incubates and applies
voltage to one or more layers, and thus produces cells and/or
a tissue construct. In another aspect, the invention provides
a method of manufacturing the assembly including the steps
of providing a first pre-electroded substrate surface; elec-
trospinning a first substantially aligned polymer fiber layer
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onto the first surface; providing a second pre-electroded
substrate surface; electrospinning a second substantially
aligned polymer fiber layer onto the second surface; and,
retaining together the layered surfaces with a clamp and/or
an adhesive compound.
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ALIGNED AND ELECTROSPUN
PIEZOELECTRIC POLYMER FIBER
ASSEMBLY AND SCAFFOLD
CROSS-REFERENCE TO RELATED
APPLICATIONS
This patent application is a divisional of co-pending U.S.
patent application Ser. No. 14/685,204, filed Apr. 13, 2015;
which is a divisional of U.S. patent Ser. No. 12/969,076,
filed Dec. 15, 2010, now issued as U.S. Pat. No. 9,005,604;
which claims the benefit of and priority to U.S. Provisional
Patent Application No. 61/286,484, filed Dec. 15, 2009. The
contents of the foregoing applications are hereby incorpo-
rated by reference in their entireties.
STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH AND
DEVELOPMENT
This invention was made in part by employees of the
United States Government and may be manufactured and
used by or for the Government of the United States of
America for governmental purposes without the payment of
any royalties thereon or there for.
BACKGROUND OF THE INVENTION
Current scaffold designs and materials do not provide all
of the appropriate cues necessary to mimic in vivo condi-
tions for tissue engineering and stem cell engineering appli-
cations. It has been hypothesized that many biomaterials,
such as bone, muscle, brain and heart tissue exhibit piezo-
electric and ferroelectric properties. Typical cell seeding
environments incorporate biochemical cues and more
recently mechanical stimuli. However, electrical cues have
just recently been incorporated in standard in vitro exami-
nations. In order to develop their potential further, novel
scaffolds are required to provide adequate cues in the in vitro
environment to direct stem cells to differentiate down con-
trolled pathways or develop novel tissue constructs. A
scaffold that provides electrical stimuli in conjunction with
biochemical and mechanical cues will have a significant
impact on the proliferation and differentiation of stem cells
and tissue constructs that can be engineered.
BRIEF SUMMARY OF THE INVENTION
In view of the foregoing, it is an object of the invention
to provide a scaffold assembly and related methods of
manufacturing and/or using the scaffold for stem cell culture
and tissue engineering applications in order to at least
partially mimic a native biological environment by provid-
ing biochemical, topographical, mechanical and electrical
cues by using an electroactive material.
It is a related object of the invention to provide the ability
for delivering electrical and mechanical stimuli through
bioactive fibers for stem cell tissue engineering. Potential
applications include stem cell therapy treatment methods
include, for example, spinal cord disorders, autoimmune
diseases, and Parkinson's disease. Potential applications
also include, for example, tissue engineering constructs for
myocardial infarcts, blood vessels, and skin grafts.
These objects are achieved by the present invention,
which in one embodiment provides an assembly for tissue
engineering and/or stem cell differentiation using electrical
and/or mechanical stimuli through bioactive fibers compris-
2
ing at least one layer of substantially aligned, electrospun
polymer fiber having an operative connection for individual
voltage application.
In another embodiment, the invention provides a method
5 of cell tissue engineering and/or stem cell differentiation,
said method including the steps of providing an assembly
having at least two layers of substantially aligned, electro-
spun polymer fiber having an operative connection for
individual voltage application to each layer; seeding the
10 assembly with a sample of cells suspended in cell culture
media; incubating for an effective time period; applying an
effective voltage to one or more layers; and recovering cells
and/or a tissue construct.
In yet another embodiment, the invention provides a
15 method of manufacturing an assembly for tissue engineering
and/or stem cell differentiation including the steps of pro-
viding a first pre-electroded substrate surface; electrospin-
ning a first substantially aligned polymer fiber layer onto the
first surface; providing a second pre-electroded substrate
20 surface; electrospinning a second substantially aligned poly-
mer fiber layer onto the second surface; and, retaining
together the layered surfaces with a clamp and/or an adhe-
sive compound.
Additional objects, embodiments and details of this
25 invention can be obtained from the following detailed
description of the invention.
BRIEF DESCRIPTION OF THE SEVERAL
VIEWS OF THE DRAWING(S)
30
FIG. 1 illustrates SEM micrographs of electrospun PVDF
after (a) non-woven image collected on a static plate without
auxiliary electrode use, (b) 1-2 seconds, (c) 5 minutes, (d) 15
minutes, (e) 30 minutes, (f) 45 minutes [magnification 500x
35 (a,c,d,f), 100x (b), and 845x (e)].
FIG. 2 illustrates scaffolds fabricated from CP2 polyimide
with (a) optical image of 4 layer aligned fibers [mag. 10x],
(b) live/dead assay results on aligned fibers, (c) optical
image of nonwoven fibers [mag. 10x], and (d) live/dead
40 assay results on nonwoven fibers.
FIG. 3 illustrates SEM micrograph of a cell attached to the
surface of a CP2 fiber.
FIG. 4 illustrates a schematic drawing of an exemplary
scaffold with PVDF fibers electrospun directly onto a pre-
45 electroded surface.
FIG. 5 illustrates a schematic drawing of an assembly of
four scaffold layers in a 0/90/+45/-45 configuration.
DETAILED DESCRIPTION OF THE
50 INVENTION
Stem cells have enormous therapeutic potential for treat-
ing a multitude of medical disorders such as Parkinson's
disease, autoimmune diseases, and spinal cord injuries. An
55 attractive feature of this therapy is the ability to inject the
stem cells directly at the treatment location without the need
for additional delivery mechanisms. Adult stem cells are
currently used to treat leukemia and other blood and bone
disorders and recently have been approved as a treatment
60 strategy for myocardial infarcts and degenerative joint dis-
ease. Human mesenchymal stem cells (hMSCs) are adult
stem cells derived from bone marrow that have demon-
strated remarkable multipotency through their ability to
differentiate across germ layers. A great deal of research in
65 this area has focused on their trans-differentiation potential
and the ability to direct their differentiation to specific
lineages. A key component influencing the differentiation
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fate of stem cells is the in vitro environment in which they
are cultured for expansion. This environment is comprised
of a multitude of factors with the fundamentals being the
selection of media, 2-D vs. 3-D scaffolds, and material
considerations. Several groups have identified key differ-
ences in employing media containing serum and that free of
serum with varying results. The physical culture conditions,
however, remain rather elusive with numerous variables to
consider such as topography, spatial dimensions, material
chemistry and mechanical properties. Current scaffold
designs and materials do not provide all of the appropriate
cues necessary to mimic in vivo conditions. It has been
hypothesized that many biomaterials, such as bone, muscle,
brain and heart tissue exhibit piezoelectric and ferroelectric
properties. Typical cell seeding environments incorporate
biochemical cues and more recently mechanical stimuli,
however, electrical cues have just recently been incorporated
in standard in vitro examinations. In order to develop their
potential further, novel scaffolds are required to provide
adequate cues in the in vitro environment to direct the stem
cells to differentiate down controlled pathways. A scaffold
that provides electrical stimuli in conjunction with bio-
chemical and mechanical cues will have a significant impact
on the proliferation and differentiation of the stem cells.
The primary objectives of this invention are twofold; first,
to develop a novel scaffold that provides mechanical and
electrical cues that more closely mimic the cells' native
environment (such as heart, brain, nerve, muscle) and sec-
ond, to determine the influence of the scaffold on the
differentiation potential of exemplary human mesenchymal
stem cells. The inventive embodiments are segmented into
four key parts; the first is the manufacture of aligned
electroactive fibers that will provide the electrical and
mechanical cues; the second is to create a 3-D structure from
the aligned electroactive fibers and to design a scaffold that
combines the 3-D aligned fiber architecture with electrical
and mechanical stimulus capability; the third part is to
determine the effect of topography on exemplary human
mesenchymal stem cells phenotypic development by com-
paring 2-D vs. 3-D environments; and the fourth is to
determine hMSC phenotypic development as a function of
electrical and mechanical stimuli application.
In at least one embodiment, the invention involves the
fabrication of electroactive polymer fibers. Electrospinning
was used to yield fibers that can exhibit crystalline structures
in polar form due to the strong electric field. And since
aligned fibers are crucial in directing stem cell differentia-
tion, the electrospinning process was modified to generate
highly aligned electroactive fibers in situ using an auxiliary
electrode to focus the electric field. For more details on an
exemplary method and system for aligning fibers during
electro spinning, please see application Ser. No. 12/131,420,
which has published as US 2009/0108503 Al, which is
herein incorporated by reference.
One of the specific aims of this invention is to fabricate an
exemplary scaffold that confirms the effect of topography
and architecture on the differentiation of exemplary hMSCs.
Although hMSCs are discussed in detail, certain inventive
embodiments include other types of stem cells, e.g. induced
pluripotent and/or embryonic stem cells. Research per-
formed by Yim and Hu et. al. demonstrated the significant
influence topographical cues have in directing the differen-
tiation of hMSCs. It was observed that hMSCs respond to
features in the nanometer and micrometer range. The for-
mation of the extracellular matrix has been shown to occur
on the nanometer level making this an attractive dimension.
Other groups have investigated the effect of surface chem-
4
istry on the attachment, proliferation and differentiation of
hMSCs. Engler et. al. reported that a material's elastic
modulus alone is capable of directing stem cell differentia-
tion. They found that collagen production was significantly
5 reduced when hMSCs were cultured on a `soft' matrix
compared to a ` hard' matrix intended to mimic the differ-
ences between biomaterials such as the brain and bone. In
addition to topography, the architecture contributes consid-
erably to the overall success of the scaffold. A scaffold
io comprising a three dimensional environment more closely
mimics native surroundings than one constructed from two
dimensions. There are two predominant scaffold constructs
that provide a three dimensional environment, gels and
fibers. Gels produced from collagen, fibrin, gelatin, alginate,
15 and more recently thermoresponsive polymers demonstrate
differing results compared to conventional two dimensional
systems when used to culture hMSCs. Scaffolds fabricated
from fibers with diameters ranging from nanometers to
micrometers have also been investigated extensively as three
20 dimensional constructs. Interesting results have been
observed with this type of environment. One study com-
pared the effects of a three dimensional gel environment to
a fibrous scaffold and found vastly differing results between
the two. Another scaffold was designed to mimic native
25 cartilage by employing a composite structure manufactured
to emulate the mechanical properties. A key issue confront-
ing three dimensional scaffolds to date is control over the
porosity. Porosity is vital to the health and maintenance of
the cells in culture. If the porosity is insufficient, the cells
30 will not receive adequate nutrients and may undergo
hypoxia. One way to prevent this is to use aligned fibers to
control porosity. Aligned fibers have been investigated
extensively and shown to promote cell alignment and attach-
ment due to their high surface to volume ratio. Studies
35 suggest that a fibrous structure plays a fundamental role in
the modeling of the extracellular matrix and overall gene
expression.
Some embodiments of the invention involve electroactive
polymer fibers, and in preferred embodiments, the polymer
40 fibers used are composed of polyvinylidene fluoride
(PVDF). PVDF is a commercially available polymer used in
a variety of areas ranging from aerospace, medical, and
automotive to common household applications. It is a crys-
talline material capable of assuming four different phases (a,
45 (3, y, 6) depending upon processing and post-processing
conditions. The y and 6 phases are quite uncommon and will
not be examined for this study. The most common form is
the a-phase. The crystalline structure is in a trans-gauche
(TGTG) configuration. When the material is mechanically
50 stretched its crystalline form is altered to assume an all-trans
configuration, which renders it electroactive due to align-
ment of the dipoles present in the structure. Subjecting the
mechanically stretched material to an electric field further
increases the dipole alignment in the crystalline structure
55 and enhances the electroactive properties. This highly polar
form is classified as the R-phase and is the desired state due
to its unique electroactive properties. Electroactive PVDF is
in a class of materials that exhibit piezoelectricity, i.e. a
mechanical strain is elicited with the application of a voltage
6o and conversely, an electrical signal is produced with the
application of a mechanical strain. It is also pyroelectric,
exhibiting an electric charge as a function of temperature.
This is typically referred to as ferroelectric. PVDF poses an
exciting possibility for cell culture studies for at least two
65 reasons. First, the piezoelectric properties of the R-phase
allows for direct application of electrical and mechanical
stimuli to the cells. Second, its pyroelectric property result-
US 10,196,603 B2
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ing from an applied temperature is novel. Thermally stimu-
lated current (TSC) data indicates that PVDF generates a
slight current equivalent to approximately 2.2E-10 A/m2
when subjected to standard cell culture conditions of 37° C.
This property was included in the analysis during the
topographical portion of the study. PVDF has been consid-
ered for a wide range of biomedical applications such as
sutures and surgical meshes due to its inert chemistry and
good biocompatibility.
Exemplary human mesenchymal stem cells (hMSCs)
have generated an enormous amount of interest due to their
multipotency, the fact that they are non-controversial and
they do not form teratomas. IrMSCs have demonstrated
multipotent potential through their ability to trans-differen-
tiate. Several research groups have reported success in
directing IrMSCs to differentiate into adipocytes, chondro-
cytes, osteoblasts, neurons, cardiomyocytes and muscle.
There is considerable debate as to whether IrMSCs actually
trans-differentiate or are coerced into specific lineages by
fusion with mature cells present in their surroundings.
Research by Engler et. al. has provided additional clarifica-
tion surrounding this highly controversial topic with their
discovery on the multipotent potential of IrMSCs based on
the modulus of the scaffold. Their study revealed a passive
response of the IrMSCs to the microenvironment which is
presumed to be indicative of a multipotent stem cell.
Although IrMSCs trans-differentiation potential has
sparked a great deal of debate among the research commu-
nity, there is no dispute regarding the multipotent potential
of IrMSCs and their ability to be considered for therapeutic
applications. In fact, IrMSCs are an ideal research line
because they are not controversial since they are derived
from bone marrow and in many instances, they can be
autologous, eliminating immunorejection concerns. Embry-
onic stem cells, while undoubtedly pluripotent, have gener-
ated a significant degree of controversy primarily over
sourcing. It will be challenging for human embryonic stem
cells to be considered for clinical applications in the near
term for this reason and also because they are extremely
difficult to control, often giving rise to tumor formation.
In order to direct stem cell differentiation in vitro, it is
necessary to provide the appropriate cellular cues and envi-
ronment. This includes biochemical, mechanical and elec-
trical signals that emulate the native cellular environment.
Typically, cells are seeded in a tissue culture treated poly-
styrene dish and provided with biochemical cues to guide
them down a specific lineage. This has demonstrated mod-
erate success, but does not emulate the cells native environ-
ment. Researchers have recently begun to investigate the
effects of mechanical properties on the growing cells. They
have demonstrated that providing a mechanical environment
similar to a cell's native area contributes significantly to the
lineage pathway chosen. Another group of researchers has
shown that providing electrical signals to embryonic stem
cells results in a much larger number of cells exhibiting
markers for a neuronal pathway. In order for stem cell
therapy to become viable, cells must be harvested, dissoci-
ated into individual cells and expanded ex vivo. Stem cells
that can be differentiated into a preferred lineage and
expanded down that pathway possess the ability to provide
great therapeutic potential for numerous health disorders.
IrMSCs are currently being considered for treatment in
Parkinson's disease and other neural disorders due to their
demonstrated ability to trans-differentiate or by creating a
favorable environment through the release of soluble fac-
tors.
T
There are a multitude of neurological and immune disor-
ders that, despite society's best efforts, their cures remain
elusive in the research community. In order to treat these
conditions, new methods and clinical treatments must be
5 considered. Technology has brought about substantial medi-
cal advances through the introduction of state-of-the-art
diagnostic equipment and the ever changing drug therapies
available. It is necessary to step around some of the current
barriers to treatment and examine new options. Stem cell
io therapy offers boundless potential for improving the quality
of life for millions of individuals, possibly even offering
cures for diseases previously unattainable. Hence, despite
numerous obstacles, research into IrMSCs for stem cell
therapy remains robust.
15 Inventive materials selected included PVDF, which was
selected for its unique electroactive properties and its poten-
tial for biocompatibility. A fluorinated polyimide, CP2, was
also selected and synthesized from 2,2'-Bis (3,4-dicarboxy-
phenyl) hexafluoropropane dianhydride (6FDA) and 1,3-bis
20 (4-aminophenoxy)benzene (APB) and was included to com-
pare to the PVDF due to its potential for biomedical
applications. The biocompatibility of electroactive PVDF
was verified by performing a live/dead assay and examining
the metabolic activity compared to standard tissue cultured
25 polystyrene (TCPS) and a polyimide, CP2. The cells dem-
onstrated good spreading and morphology on both film
surfaces. A WST-1 assay confirmed the metabolic activities
of PVDF and CP2 were comparable to TCPS indicating
good biocompatibility between IrMSCs and PVDF. Since the
30 surface of the material plays a critical role in the cell
attachment and spreading, we analyzed the films for func-
tional groups present, surface roughness, and surface energy.
FTIR-ATR results indicated the presence of primary ali-
phatic OH functional groups for PVDF by the peaks
35 present at 1066 cm-1 and —3600 cm-1. Aliphatic POOH
functional groups were identified in the spectra for CP2 by
the broad OH stretching region from 2500-3500 cm-1 and
peaks present at 1072 cm-1, 1239 cm-1 and 1720 cm-1. It
has been reported that OH and —COOH functional
40 groups play a significant role in cell attachment and prolif-
eration. Several research groups have attempted to add these
functionalities to their materials to enhance these features
and promote proliferation.
Contact angle measurements were performed on each film
45 surface using media warmed to 37° C. and found to be
67.34° for PVDF and 78.68° for CP2 at equilibrium indi-
cating the surfaces were hydrophilic. The surface energy
was calculated based on the equilibrium contact angle
observed and was found to be 34.91 dynes/cm for PVDF and
50 26.02 dynes/cm for CP2. These values are quite low for a
hydrophilic material however, the surface roughness is not
included in the theoretical equation although it contributes
significantly to the wettability of the surface. The average
surface roughness for each material was found to be 0.069
55 µm for PVDF and 0.009 µm for CP2 indicating sufficient
roughness to promote adhesion at the cellular level. The
results were illustrated with images obtained using an opti-
cal profilometer.
Several researchers have reported a significant reduction
60 in electroactive properties over a period of time when
exposed to in vivo conditions. Therefore, an in vitro degra-
dation study was performed on PVDF to ensure the material
properties were not changed as a result of long term expo-
sure to the environment.
65 The mechanical properties were measured on five PVDF
samples and averaged over the degradation period. There
was very little change over the 28 day period with overall
US 10,196,603 B2
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about 4% difference between the baseline and the last day
for the ultimate break stress, 7% difference in the elongation
and about a 5% difference in the modulus. There was not a
reportable difference in the piezoelectric properties over the
28 day period as indicated by the thermally stimulated
current method.
The electrospinning manufacturing process is a simple
and versatile process that can be used to fabricate micro and
nanofibers from polymer solutions and melts. The process
has typically produced random nonwoven mats and was
modified for this study to develop aligned fibers for a more
controlled architecture. The set-up incorporates an auxiliary
electrode that creates a dipole field and directs the electro-
spun fiber to a collector without the typical whipping and
bending instabilities observed in other systems. The fiber
continues to be pulled along the dipole field over time and
can be directed at an angle due to the repositioning of the
auxiliary electrode. SEM micrographs illustrated in FIG. 1
demonstrate the degree of alignment achieved for various
time periods ranging from 1 second to 45 minutes.
The crystalline structure of PVDF aids in determining the
overall properties of the resulting polymer, specifically, the
piezoelectric state. A common technique to induce the
R-phase is to subject the a structure to mechanical stretching
and a high electric field which results in orientation of the
dipoles within the crystalline structure. Electrospinning
incorporates both of these features; first by mechanically
drawing the fiber from the spinneret to the collector and
second by creating a strong electric field which the fiber is
expelled through. The results from electrospinning a pure
a-phase powder from a solution of 50/50 DMF:Acetone
indicate a transition to the R-phase occurred based on peak
shifts illustrated in the x-ray diffraction (XRD) diffracto-
gram. When examining the material using XRD, there are
two primary peaks indicating the starting crystalline form is
in the alpha phase. A shift of 20 to 20.6° indicates 200/110
reflections of the R-phase whereas the two shoulder peaks at
20=18.25° and 19.8° represent the 020 reflection of the
a-phase. The peak around 20=26.63° is representative of the
a-phase. This peak was not present in any of the processed
forms present in the diffractogram indicating a shift from the
a-phase to the R-phase occurring. The electrospun nonwo-
ven PVDF showed a peak shift around 20=28.57° suggest-
ing it has not fully transitioned to the (3-phase. An additional
peak around 20=36.14° represents the 200 plane and is
another indicator that the R structure has been formed.
Fourier transform infrared spectroscopy (FTIR) with
attenuated total reflectance confirmed the transition to the
R-phase by a change in the vibrational bands characteristic
of the a-phase at 615 cm-1, 766 cm-1 and 795 cm-1 and the
presence of a vibrational band at 840 cm-1. Differential
scanning calorimetry (DSC) results for the electrospun
aligned fiber depicted a melting point of approximately 160°
C. on the first heat. Subsequent quenching and a second heat
indicated a shoulder peak present at 155° C. and 160° C.
which was indicative of the two crystalline phases present,
further demonstrating the crystalline R-phase transforma-
tion. The melting temperature for the electrospun aligned
fibers was lower than that for the poled film (165' C.). There
are several factors that may contribute to the slight decrease.
The number of head-head and tail-tail chain configurations
will play a role in the overall melting point as will the
percent crystallinity and the amount of a-phase and R-phase
present. The presence of a shoulder peak in the poled film
and its absence in the pure powder further signifies the
presence of both phases.
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A modified Rheovibron was used to measure the d31
piezoelectric constant of a fibrous mat electrospun from
PVDF for 45 minutes. Gold electrodes were deposited on
both sides of the mat and measurements were performed by
5 applying a tensile load of 35 g and measuring the d31
constant as a function of frequency and temperature. Results
were obtained for frequencies at 1 Hz, 10 Hz, 20 Hz and 100
Hz over a temperature range of 23° C. to 50° C. A value for
d31 was obtained, thus validating the rationale that electro-
io spun aligned PVDF fibers are poled in-situ during the
electrospinning process.
As discussed earlier, topography plays a significant role in
cell attachment, differentiation and proliferation of exem-
plary hMSCs. In order to determine the effect of fiber
15 morphology on the culture of hMSCs, the inventors per-
formed cell culture studies on films of the same material to
be examined in fiber form. Preliminary results from exam-
ining the cells after 7 days and 14 days in culture indicate
advanced cell structure by the presence of intermediate
20 filament vimentin. A strong presence of beta III tubulin
(TU71), an early stage neuronal marker, was present for all
of the materials and MAP2 was present in the group con-
ditioned with retinoic acid and PVDF. Retinoic acid has
been identified as a chemical agent that induces the neuronal
25 lineage in culture. Reverse transcriptase PCR was performed
on mRNA extracted from the samples after 7 days and 14
days in culture. Gel electrophoresis staining indicated the
upregulation of Oct 4, a marker typically present in embry-
onic stem cells, for the CP2 polyimide coverslip, coverslip
30 with retinoic acid and TCPS after 14 days in culture. Genes
corresponding to C-kit were present in PVDF and coverslip.
All of the material samples expressed SOX 9, an early
marker for chondrycyte formation and alpha-fetoprotein
(AFP). AFP is a protein expressed during early endoderm
35 development and has been shown to express in hMSCs
during hepatocyte differentiation. PVDF also indicated the
upregulation of MAP2 after 14 days in culture. This indi-
cates there may be something happening on the cell signal-
ing level with PVDF, perhaps related to the pyroelectric
4o behavior, since MAP2 is a gene expressed during neuronal
development. The expression of both endoderm and meso-
derm markers suggested a mixed population of cells present.
Gel electrophoresis data for the 7 day films did not readily
express any of the genes the inventors probed for although
45 the housekeeping genes, beta actin and GADPH, were
clearly observed.
In order to determine the effect of PVDF fibers on the
culture of hMSCs, scaffolds were manufactured from both
CP2 polyimide and PVDF. The fibers were electrospun
5o directly onto rings to be used in culture and affixed using
cyanoacrylate. The fibers were deposited in a configuration
to allow the greatest degree of porosity while maximizing
cell attachment. Three different aligned fiber configurations
were examined. The `standard' configuration was composed
55 of fibers having average diameters of approximately 8µm,
the ` fine' sample fiber diameters were on the order of 1µm
and the ` mixed' sample consisted of a basement layer of fine
fibers followed by three additional layers of standard sized
fibers. The lay-up was in a 0/90/+45/-45 arrangement for
60 each sample type. A sample comprised of a nonwoven
collection of fibers was used to assess the impact of aligning
the fibers. Initial studies examined the effect of this archi-
tecture by performing live/dead assays on fiber scaffolds
manufactured from CP2.
65 The results are illustrated in FIG. 2. It is apparent from the
results, which indicated the presence of some dead cells, that
the nonwoven scaffold either did not allow the appropriate
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nutrients to diffuse through the scaffold or that the cells
could not penetrate the scaffold for proper attachment. The
aligned fibers, although quite auto-fluorescent, provide a
good environment for cell culture as can be observed by the
cell attachment along the length of the fibers and throughout
the multiple layers. An SEM micrograph depicting a dehy-
drated cell attached to a CP2 fiber is illustrated in FIG. 3. Gel
electrophoresis results indicated the presence of Sox 9, a
marker for chondrocyte formation, for each of the CP2 fiber
sizes and architectures examined after 7 days in culture.
Immunostaining of CP2 aligned fibers for vimentin, actin
and the nucleus revealed a well organized cell. The cells
showed substantial alignment along the fibers. The mixed
fibers did not display a cell structure as organized as those
observed on the standard and fine fibers. The nucleus was
much more elongated on the fine fibers compared to the
standard fibers. This suggests the cell was sitting on top of
the standard size fibers since they are roughly the same size
and the cell was elongating and perhaps wrapping around
the fine diameter fibers in order to attach.
PVDF fibers were also electrospun onto rings, in the
configuration described above for CP2, and affixed with
cyanoacrylate, cultured for 7 days and stained for vimentin,
actin and the nucleus. The cells were observed with confocal
microscopy to attach to the fibers. The nucleus was elon-
gated along the length of the fiber illustrating the influence
of topography on the cell morphology. It was also observed
that what appears to be two cells attached to different fibers
bridged across the fibers to contact one another.
In at least one embodiment of the invention, an assembly
for tissue engineering and/or stem cell differentiation is
provided using a 3-D scaffold to apply electrical stimuli. In
one embodiment, at least several factors were considered in
the design of the 3-D scaffold in order to apply electrical and
mechanical stimulation. These included the geometry, sub-
strate, electroding, adhesive, clamp fixture and fiber depo-
sition. An exemplary 3-D scaffold was designed such that
PVDF fibers could be electrospun directly onto a pre-
electroded (FIG. 4) surface minimizing the potential for
shorting by electroding the fibers post-processing. The plan
in this instance was to manufacture four layers indepen-
dently, place them in a 0/90/+45/-45 configuration (FIG. 5)
and retain them with a specially designed clamp. This
allowed for the direct stimulation of each layer indepen-
dently. The four layer assembly mimicked the architecture of
the previous work with the fibers manufactured onto rings in
order to allow for a more direct comparison. Cell culture
studies were performed on the scaffolds with the application
of voltage to each layer.
Accordingly, each substrate layer was fabricated using
KaptonTM polyimide (DuPont) by laser cutting a 28 µm sheet
of film. Gold electrodes were evaporated on each substrate.
Gold was chosen as the electrode material due to its inert
properties and excellent biocompatibility. DevconTM silicon
adhesive was used to glue the electrospun fibers to the
electroded substrates. Each layer was fabricated separately,
glued and allowed to air dry for a minimum of 48 hours. The
four separate layers were joined together using the silicon
adhesive and allowed to dry for a minimum of 48 hours prior
to cell culture.
A clamp was designed to hold the four layer scaffold
construct together and keep it suspended from the bottom
surface and allow for each layer to be stimulated indepen-
dently or simultaneously. A grooved portion provided space
for the flexible leads to extend outside of the culture area and
the top piece secured the scaffold together by fitting snugly
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into the grooved piece. The clamp was fabricated from
acrylic polymer resin using the stereolithography rapid
protyping process.
In order to maintain the existing architecture for compari-
5 son purposes, a similar design will be employed with one
end of the substrate fixed and the free end mechanically
extended in order to strain the PVDF fibers. The substrate
will be cut on each side in order to obtain direct straining of
the fibers without the influence of the substrate. Mechani-
io cally straining the fibers will elicit an electrical signal that is
expected to have a significant impact on the differentiation
and proliferation of the hMSCs over time.
Exemplary human mesenchymal stem cells were obtained
from Tulane University. A single male donor was used
15 throughout the study to prevent donor-donor variables.
hMSCs were cultured in alpha minimum essential medium
(oLMEM) with L-glutamine, but without ribonucleosides or
deoxyribonucleosides (Invitrogen/GIBCO), containing
16.5% fetal bovine serum, premium select, hybridoma quali-
20 fied, not heat inactivated (FBS, Atlanta Biologicals), 200
mM in 0.85% NaCl of L-glutamine (Invitrogen/GIBCO),
100 units/ml penicillin and 100 µg/ml streptomycin (Invit-
rogen/GIBCO). Cell culture medium was filtered through a
sterile filter unit. Cells were plated at an initial density of
25 approximately 350 cells/cm2 in a 15 cm dish and incubated
at 37° C. with humidified 5% CO2. Media was replenished
every three days. Cells were passaged after reaching
approximately 80% confluence by aspirating media, wash-
ing Ix with phosphate buffered solution (PBS, Invitrogen)
3o and lifting with 0.25% Trypsin and 1 mM ethylene diamine
tetracetic acid (EDTA) in Hank's balanced salt solution
(Invitrogen/GIBCO) for 1-3 minutes at room temperature.
After incubation in Trypsin/EDTA, 5 ml of cell culture
media was added and the mixture was transferred to a 15 ml
35 conical centrifuge tube. The cells were centrifuged for 10
minutes at 450xg at room temperature. The supernatant was
aspirated and the cell pellet resuspended in 1.0 ml cell
culture media. Cells were counted by adding 10 µl 0.4%
Trypan Blue solution to 10 µl of cell suspension and
4o dispersing them onto a hemocytometer. Cells were seeded
onto scaffolds between passages 2-5 at a density of approxi-
mately 125,000 cells/cm2. Attachment of the cells to the
scaffold was promoted by seeding an initial volume of 250
µl of cell suspension on each scaffold and allowing it to
45 incubate at 37° C. with humidified 5% CO2 for a minimum
of one hour. After the initial incubation period, an additional
volume of 3-4 ml of cell culture media was added to each
well and the scaffold was placed back in the incubator at 37°
C. with humidified 5% CO2 for 7 days. Media was replen-
50 ished every three days. Electrical leads clamped to the
flexible leads of the scaffold were attached to a power supply
and a 9 mV/cm stimulus was applied to each scaffold layer
after approximately 24 hours post-seeding at a frequency of
500 mHz.
55 In order to determine an exemplary minimum voltage
required to cause an effect on the calcium channels, a
preliminary calcium imaging experiment was performed
using a Fluo-4 NW (no wash) assay (Molecular Probes).
PVDF and CP2 polyimide films were examined. Films were
60 laser cut to provide a flexible lead and An electrodes were
evaporated on the surface in order to attach wires to the
substrates. hMSCs were seeded on PVDF and CP2 films at
a density of 5000 cells/cm2 and allowed to incubate for 24
hours at 37° C. in humidified 5% CO2. A 250 mM stock
65 solution of probenicid was prepared by adding 1 mL of assay
buffer to probenicid and vortexing until dissolved. The dye
loading solution was prepared by adding 10 mL assay buffer
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and 100 µL probenicid stock solution to Component A and
vortexing for 1-2 minutes. A 1µM acetylcholine (AcH)
(Sigma-Aldrich) sample was prepared in buffer. To prepare
for imaging, media was removed from the wells and the
samples were washed 2x with PBS. A volume of 1 mL of dye
loading solution was added to each sample and the samples
were incubated at 37° C. in humidified 5% CO2 for 30
minutes. The samples were placed under an upright fluo-
rescent microscope (Zeiss Axio Observer) fitted with a
heated stage. Wires were attached to the flexible electrodes
protruding outside of the chamber. The voltage supply
(Keithley) was monitored using an oscilloscope (Wavetek).
Data was recorded for a period of 2 minutes prior to the
application of stimuli. AcH was added after several minutes
of baseline data collection and served as a positive control.
Power was applied to the substrate and recorded for several
minutes. Data was obtained and post-processed using Meta-
morph software (Zeiss). The average fluorescence intensity
for a minimum of 7 cells was plotted as a function of time.
Results from the live cell calcium imaging study indicated
that application of 9 mV/cm of a direct current electric field
was sufficient to elicit a response in the cells. The addition
of AcH showed a peak intensity of about 600 while the CP2
film with 9 mV/cm direct current electric field applied had
an intensity of around 1100, nearly two times the results
obtained with AcH. The PVDF film peaked around 625,
similar to the results obtained using AcH to stimulate the
Ca+ channels. Spontaneous Ca+ signals were observed in
the PVDF film prior to the application of 9 mV/cm direct
current electric field.
The proliferation of cells was analyzed using EdU Click-
iTTM Imaging Kit (Invitrogen). Cell culture was performed
as described above. Briefly, hMSCs were seeded on scaf-
folds and in a 6 well tissue culture dish at a density of
200,000 cells. After 24 hours in culture, EdU was added to
the media at a concentration of 10 µM. After 3 days in
culture, media was replenished with fresh media containing
10 µM of EdU. After 7 days, the samples were removed,
fixed with 4% PEA (Sigma-Aldrich) for 15 minutes at room
temperature then washed 2x with PBS containing 3% bovine
serum albumin (BSA, Sigma-Aldrich). After the wash was
removed, the samples were incubated for 20 minutes at room
temperature in 0.5% TritonX-100 in PBS. The reaction
cocktail was prepared by mixing 1.8 mL 1 x Click-IT reac-
tion buffer, 80 µL CuSO4, 5µL Alexa Fluor azide, and 200
µL reaction buffer additive. The permeabilization buffer was
removed and the samples were washed 2x with PBS con-
taining 3% BSA. The wash was removed and the Click-iT
reaction cocktail was added to each sample. The samples
were incubated for 30 minutes at room temperature pro-
tected from light. The reaction cocktail was removed and the
samples were washed with PBS containing 3% BSA. Each
sample was washed with PBS prior to DNA staining. A
Hoechst 33342 (1:2000) was added to each sample and
incubated for 30 minutes at room temperature protected
from light. The samples were washed 2x in PBS and
mounted to coverslip with gel mount (Invitrogen). The
samples were imaged using confocal microscopy. A mini-
mum of 400 cells were counted.
Proliferation results for the PVDF fiber stimulated scaf-
fold and TCPS indicated the stimulated scaffold had 10%
greater incorporation of EdU compared to TCPS, with 33%
EdU-positive cells in the stimulated fiber scaffold compared
to 23% on TCPS.
Immunostaining was performed. After 7 days in culture,
samples were washed with PBS and fixed in 4% paraform-
aldehyde for 15 minutes at room temperature. Following
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fixation, the samples were washed 2x in PBS. A solution
containing 0.25% Triton-X 100, 1% bovine serum albumin
and 10% goat serum was prepared in PBS. Samples were
probed for primary antibodies including Vimentin (1:200,
5 Sigma-Aldrich), F-Actin (1:50, Molecular Probes), TU71
(1:500, Covance), MAP2 (1:400, Sigma-Aldrich), and DAPI
(1:5000, Molecular Probes) and allowed to incubate for 2
hours at room temperature. The samples were washed 3x
with PBS and secondary antibodies of Alexa-Fluor conju-
10 gated goat anti-mouse (1:200) and goat anti-rabbit (1:200)
were added and allowed to incubate for a minimum of 1 hour
at room temperature covered with aluminum foil to protect
them from light. The samples were washed 2x with PBS and
mounted to coverslips using Gel-mount (Invitrogen). The
15 samples were imaged using laser scanning confocal micros-
copy.
Immunostaining results from examining the cells after 7
days in culture on PVDF fibers stimulated with 9 mV/cm
direct current applied field indicate advanced differentiated
20 cell morphology by the presence of intermediate filament
vimentin. The cells attached to multiple layers of the scaf-
fold with the nuclei highly aligned along the fibers. Vimentin
appeared to be forming a network across the fibers similar to
what was observed in the culture on CP2 and PVDF fibers.
25 Neuronal markers MAP2 and TU71 were evident.
Western Blot was performed. Determining the protein
concentration was performed. After 7 and 14 days in culture,
protein was extracted from the cells attached to the scaffolds
by placing the dish on ice, aspirating the media, washing 1 x
30 with PBS and adding 250 µl RIPA buffer (Pierce) containing
1:100 Halt Protease Inhibitor (PI, Pierce) cocktail (100 mM
AEBSF•HCI, 80 µM Aprotinin, 5 mM Bestatin, 1.5 mM
E-64, 2 mM Leupeptin, 1 mM Pepstatin A) to prevent
protein degradation. The lysis buffer containing the
35 extracted proteins was transferred to a 2 ml microcentrifuge
tube and stored at —80° C. until use. The protein concen-
tration was quantified using the bicinchoninic acid (BCA)
kit (Pierce). A standard curve was generated using BSA. The
Gel was prepared, loaded and run. The protein sample
40 containing 2x Laemmli buffer (Sigma-Aldrich) was heated
at 95° C. for 5 minutes and centrifuged briefly prior to
loading. Polyacrylamide Ready Gels (Biorad) having a
range from 5-20% and 30 µl wells were placed in the
electrophoresis chamber. The chamber was filled with
45 1xSDS-PAGE running buffer consisting of Tris base (25
mM, pH 6.8), Glycine (192 mM) and SDS (0.1%) in
deionized water. The standard was made from Precision Plus
Protein Kaleidoscope Standard (Biorad) and 5.5 µl was
loaded into the first well of each gel. 10 µg of protein was
50 loaded in the gel. The gel was run at 180 V for 55 minutes.
The Gel was transferred. The gel was removed and placed
over a pre-wetted nitrocellulose transfer membrane. The gel
and transfer membrane were assembled and placed in the
chamber with the gel facing the anode and membrane facing
55 the cathode. An ice block was added to the chamber and it
was filled with transfer buffer consisting of Trisbase (25
mM), Glycine (192 mM) and Methanol (20%). The set-up
was transferred to the cold room and run for 90 minutes at
80 V.
60 Primary and Secondary Antibodies were added. A 100 ml
solution of 5% nonfat milk (Biorad) in 1 xTBS (50 mM Tris
pH 8.0, 150 mM NaCI) containing 0.1% Tween 20 (Sigma-
Aldrich) was prepared for blocking. The transfer membrane
was removed from the chamber, stained with Ponceau S
65 non-specific protein stain (Sigma-Aldrich) and cut using a
razor blade at the expected molecular weight ranges for each
protein being probed. The samples were placed in the milk
US 10,196,603 B2
13
solution to block for a minimum of one hour. The primary
antibody was added according to the following dilutions:
MAP2 (1:500), Nestin (1:500), GAPDH (1:200), Actin
(1:6000), MyoD (1:200), Myogenin (1:200) and GFAP
(1:500). The samples were incubated in the primary anti-
body overnight in the cold room on a rocker. The samples
were then washed 3x with TBS containing 0.1% Tween 20
for 5-10 minutes each wash. The secondary antibodies,
Mouse-HRP (horseradish peroxidase) (1:5000, Novagen)
and Rabbit-HRP (1:3000, Biorad), were added to a 5% milk
(Biorad) solution. The samples were incubated in the sec-
ondary antibodies for a minimum of one hour. The samples
were then washed 3x with TBS containing 0.1% Tween 20
for 5-10 minutes each wash.
Chemiluminescent Detection was performed. The anti-
body detection solution was prepared by mixing component
A and B in a 40:1 ratio. The samples were prepared for
imaging by placing Saran wrap over a piece of cardboard
and reassembling each membrane on the Saran wrap. The
antibody detection mixture was added to the membrane and
allowed to incubate for 5 minutes in the dark. The detection
mixture was carefully blotted to remove any excess and
Saran wrap was placed over the top of each membrane. The
membrane was exposed to the camera without a filter for two
time periods, 5 minutes and 10 minutes in the Alpha
Innotech Fluorochem Imager. The data was analyzed using
the A1phaEase F1uorChem software by normalizing the
protein bands to the housekeeping protein GAPDH.
Western blot analysis showed the expression of MAP2
(72 kDa) protein in stimulated PVDF fibers. Protein content
was quantified by normalizing to the housekeeping protein
GAPDH. In comparison to the results obtained for CP2 and
PVDF fibers there was much lower expression of MAP2 (72
kDa) protein for both the CP2 and PVDF fibers compared to
the PVDF stimulated fibers.
In summary, culturing hMSCs on an exemplary scaffold
designed to provide electrical stimulation succeeded in
demonstrating the formation of an organized cytoskeleton.
In contrast, Titushkin et al. reported that the application of
2 V/cm direct current electrical stimuli to hMSCs resulted in
membrane detachment from the cytoskeleton. There are
several possible reasons for the differences observed. The
field applied in our design was much lower at 9 mV/cm
compared to Titushkin's. Furthermore, the field applied to
the PVDF fibers was used by the PVDF fibers to stimulate
the dipoles in its crystalline structure resulting in an indirect
effect on the cells. One could think of this as the PVDF fibers
enabling the conversion of the applied voltage to a mechani-
cal strain on the fibers. Although this electric field was
substantially lower than what is required to elicit a mechani-
cal response in the PVDF at the macroscale, any movement
in the molecular structure most likely can be felt by the cells
due to their highly sensitive nature.
The proliferation results indicate the stimulated PVDF
fibers incorporated about 10% more EdU than the TCPS.
Previous studies investigating the proliferation of hMSCs
when cultured on nanotopography show a decrease in the
proliferation compared to TCPS due to the influence topo-
graphical cues have on the differentiation of the cells. One
explanation for our results may be due to the 3D architecture
of the scaffold. The cells attached to the multiple layers may
have had access to more surface area for proliferation
compared to a 2D environment. A high seeding density may
have also caused reduced proliferation in TCPS since
hMSCs are contact inhibited cells, i.e. they stop dividing
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when they reach confluence. It would be worth repeating the
experiment at different seeding densities to determine the
influence of this parameter.
The results obtained for protein expression indicate the
5 stimulated PVDF fibers are producing MAP2 protein.
Immunostaining for this protein confirms the presence
although at a low level. MAP2 has several isoforms asso-
ciated with it resulting in expression at different molecular
weights, 72 kDa (MAP2c), 100 kDa (MAP2d) and kDa
io (MAP2a). The PVDF stimulated fibers expressed a wide
band at 72 kDa but no presence of the other isoforms was
detected. This may indicate the differentiation process is
occurring at a much slower rate which correlates well with
the enhanced proliferation observed. CP2 and PVDF fibers
15 showed strong bands for the isoform at 100 kDa and all
materials showed very weak or no presence at 239 kDa. The
precise role of each isoform has been described by Kaval-
laris et al. as having distinct cellular functions. They explain
that in the early stage of development and differentiation,
20 lower molecular weight isoforms MAP2c and MAP2d form.
The higher molecular weight isoforms, MAP2a and MAP2b,
are found exclusively in dendrites of neuronal cells with
MAP2a being the highest molecular weight found in late
stage development and MAP2b present in embryonic and
25 adult stages. MAP2d is expressed as alternative splicing of
MAP2, is developmentally regulated and found in neuronal
cell bodies. MAP2c has been expressed in dendrites, axons
and glial cells and has been found to express at high levels
during early brain development. This isoform is typically
3o replaced by higher molecular weight isoforms, however, it
has been found to remain in the olfactory system and the
retina. Since MAP2c is found in all cell compartments, it is
necessary to determine the molecular weight corresponding
to the presence of MAP2 to associate the findings with its
35 isoform to help understand the gene expression observed.
The presence of several isoforms for the CP2 and PVDF
fibers suggest the protein is being expressed in dendrites and
the cells are assuming a neuronal lineage.
Our results have shown the application of a direct current
40 electric field to stimulate PVDF fibers during hMSC culture
to be promising. The design developed was successful
though further studies are necessary to determine the precise
parameters (i.e. electric field, frequency, time at initial
voltage application, duration) to elicit any desired effective
45 response. The incorporation of electrical stimuli in a 3D
scaffold by employing an electroactive polymer, such as
PVDF, provides another level of stimuli during in vitro
culture and brings us closer to mimicking in vivo conditions.
All references, including publications, patent applica-
50 tions, and patents, cited herein are hereby incorporated by
reference to the same extent as if each reference were
individually and specifically indicated to be incorporated by
reference and were set forth in its entirety herein.
The use of the terms "a" and "an" and "the" and similar
55 referents in the context of describing the invention (espe-
cially in the context of the following claims) are to be
construed to cover both the singular and the plural, unless
otherwise indicated herein or clearly contradicted by con-
text. The terms "comprising," "having," "including," and
60 "containing" are to be construed as open-ended terms (i.e.,
meaning "including, but not limited to,") unless otherwise
noted. Recitation of ranges of values herein are merely
intended to serve as a shorthand method of referring indi-
vidually to each separate value falling within the range,
65 unless otherwise indicated herein, and each separate value is
incorporated into the specification as if it were individually
recited herein. All methods described herein can be per-
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formed in any suitable order unless otherwise indicated
herein or otherwise clearly contradicted by context. The use
of any and all examples, or exemplary language (e.g., "such
as") provided herein, is intended merely to better illuminate
the invention and does not pose a limitation on the scope of
the invention unless otherwise claimed. No language in the
specification should be construed as indicating any non-
claimed element as essential to the practice of the invention.
Preferred embodiments of this invention are described
herein, including the best mode known to the inventors for
carrying out the invention. Variations of those preferred
embodiments may become apparent to those of ordinary
skill in the art upon reading the foregoing description. The
inventors expect skilled artisans to employ such variations
as appropriate, and the inventors intend for the invention to
be practiced otherwise than as specifically described herein.
Accordingly, this invention includes all modifications and
equivalents of the subject matter recited in the claims
appended hereto as permitted by applicable law. Moreover,
any combination of the above-described elements in all
possible variations thereof is encompassed by the invention
unless otherwise indicated herein or otherwise clearly con-
tradicted by context.
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The invention claimed is:
1. A method of cell tissue engineering and/or stem cell
differentiation, said method comprising:
(a) providing an assembly having at least two layers of
5 substantially aligned, electrospun polymer fiber having
an operative connection for individual voltage applica-
tion to each layer;
(b) seeding the assembly with a sample of cells suspended
in cell culture media;
10 (c) incubating for an effective time period;
(d) applying an effective voltage to one or more layers;
and
(e) recovering cells and/or a tissue construct.
2. The method of claim 1, wherein the polymer fiber
15 comprises an electroactive polymer.
3. The method of claim 2, wherein the electroactive
polymer comprises polyvinylidene fluoride (PVDF).
4. The method of claim 1, further comprising the step of
mechanically stimulating one or more layers.
20 5. The method of claim 1, further comprising the step of
using the recovered cells and/or the tissue construct to treat
a human disability or disease condition.
